Accelerate Diagnostics Inc Precio/Valor contable
¿Qué es el Precio/Valor contable de Accelerate Diagnostics Inc?
El Precio/Valor contable de Accelerate Diagnostics Inc es -2.27
¿Cuál es la definición de Precio/Valor contable?
El ratio precio-valor contable representa la relación entre el valor de las acciones de una empresa y el valor contable por acción.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Precio/Valor contable de compañías en Sector Health Care en NASDAQ en comparadas con Accelerate Diagnostics Inc
¿Qué hace Accelerate Diagnostics Inc?
accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
Empresas con precio/valor contable similar a Accelerate Diagnostics Inc
- Aquis Entertainment tiene Precio/Valor contable de -2.31
- Zelira Therapeutics tiene Precio/Valor contable de -2.30
- Infinity Pharmaceuticals tiene Precio/Valor contable de -2.29
- Acreage tiene Precio/Valor contable de -2.28
- CytomX Therapeutics Inc tiene Precio/Valor contable de -2.28
- Holista CollTech tiene Precio/Valor contable de -2.27
- Accelerate Diagnostics Inc tiene Precio/Valor contable de -2.27
- Bridgemarq Real Estate Services tiene Precio/Valor contable de -2.27
- Biophytis SA tiene Precio/Valor contable de -2.25
- Optiva tiene Precio/Valor contable de -2.25
- Calumet tiene Precio/Valor contable de -2.25
- Excellon Resources tiene Precio/Valor contable de -2.25
- AA Plc tiene Precio/Valor contable de -2.24